1. Home
  2. IMUX vs QMCO Comparison

IMUX vs QMCO Comparison

Compare IMUX & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • QMCO
  • Stock Information
  • Founded
  • IMUX 2016
  • QMCO 1980
  • Country
  • IMUX United States
  • QMCO United States
  • Employees
  • IMUX N/A
  • QMCO N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • QMCO Electronic Components
  • Sector
  • IMUX Health Care
  • QMCO Technology
  • Exchange
  • IMUX Nasdaq
  • QMCO Nasdaq
  • Market Cap
  • IMUX 90.4M
  • QMCO 98.8M
  • IPO Year
  • IMUX N/A
  • QMCO N/A
  • Fundamental
  • Price
  • IMUX $0.79
  • QMCO $7.36
  • Analyst Decision
  • IMUX Strong Buy
  • QMCO Hold
  • Analyst Count
  • IMUX 5
  • QMCO 2
  • Target Price
  • IMUX $7.50
  • QMCO $19.00
  • AVG Volume (30 Days)
  • IMUX 1.3M
  • QMCO 641.4K
  • Earning Date
  • IMUX 11-06-2025
  • QMCO 09-10-2025
  • Dividend Yield
  • IMUX N/A
  • QMCO N/A
  • EPS Growth
  • IMUX N/A
  • QMCO N/A
  • EPS
  • IMUX N/A
  • QMCO N/A
  • Revenue
  • IMUX N/A
  • QMCO $266,079,000.00
  • Revenue This Year
  • IMUX N/A
  • QMCO $7.49
  • Revenue Next Year
  • IMUX N/A
  • QMCO $3.22
  • P/E Ratio
  • IMUX N/A
  • QMCO N/A
  • Revenue Growth
  • IMUX N/A
  • QMCO N/A
  • 52 Week Low
  • IMUX $0.56
  • QMCO $2.88
  • 52 Week High
  • IMUX $2.11
  • QMCO $90.64
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 42.07
  • QMCO 46.24
  • Support Level
  • IMUX $0.74
  • QMCO $7.07
  • Resistance Level
  • IMUX $0.90
  • QMCO $8.62
  • Average True Range (ATR)
  • IMUX 0.06
  • QMCO 0.42
  • MACD
  • IMUX -0.00
  • QMCO 0.07
  • Stochastic Oscillator
  • IMUX 25.02
  • QMCO 21.74

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

Share on Social Networks: